ijms-logo

Journal Browser

Journal Browser

Food Nutrition and Lipid Metabolism

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Bioactives and Nutraceuticals".

Deadline for manuscript submissions: 30 August 2024 | Viewed by 3459

Special Issue Editor

Department of Food Science and Engineering, Institute of Food Safety and Nutrition, Jinan University, Guangzhou 510632, China
Interests: functional food and nutraceuticals; lipid metabolism; metabolic disease; obesity; hypercholesterolemia

Special Issue Information

Dear Colleagues,

Lipids such as triglycerides, fatty acids, cholesterol and phospholipids play various essential roles in the human body. Dysregulation of lipid metabolism causes dyslipidemia, which is a critical factor in many kinds of human diseases, such as obesity, non-alcoholic fatty liver disease, atherosclerosis, cardiovascular disease, type II diabetes, Alzheimer’s disease, and even COVID-19.

In recent years, nutraceuticals and functional foods have attracted much interest as possible alternative therapies for lipid disorders, especially for hypercholesterolemia, hypertriglyceridemia, mixed hyperlipoproteinemia, and low HDL cholesterol.

Contributions to this Special Issue will provide new insights into the impact of food nutrition in the prevention of lipid disorders and their related diseases. Regulation of lipid-metabolism-related genes and proteins are also discussed in this Special Issue.

Dr. Rui Jiao
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • food nutrition
  • lipid metabolism
  • cholesterol
  • triglyceride
  • functional food
  • nutraceuticals
  • dietary patterns
  • cardiovascular disease
  • obesity
  • diabetes
  • COVID-19
  • molecular nutrition

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 4489 KiB  
Review
The Effect of Fenugreek in Type 2 Diabetes and Prediabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by Jiwon Kim, Woojeong Noh, Ahrim Kim, Yoomin Choi and Young-Sik Kim
Int. J. Mol. Sci. 2023, 24(18), 13999; https://doi.org/10.3390/ijms241813999 - 12 Sep 2023
Cited by 2 | Viewed by 2818
Abstract
Fenugreek is a widely used herbal medicine as a complementary therapy for diabetes mellitus. Lots of clinical trials have proved its beneficial effect on glycemic control parameters and lipid profiles. Thus, we conducted a systematic review and meta-analysis to evaluate the effectiveness and [...] Read more.
Fenugreek is a widely used herbal medicine as a complementary therapy for diabetes mellitus. Lots of clinical trials have proved its beneficial effect on glycemic control parameters and lipid profiles. Thus, we conducted a systematic review and meta-analysis to evaluate the effectiveness and safety of fenugreek as a treatment for type 2 diabetes mellitus. We searched PubMed, Embase, Cochrane, China Knowledge Resource Integrated Database (CNKI), Korean studies Information Service System (KISS), Research Information Sharing Service (RISS), and ScienceON to select RCTs which used fenugreek targeting hyperglycemia with a control group. We used either a random effect model or a fixed model in a meta-analysis of Fasting blood glucose (FBG), 2 h plasma glucose during a 75 g oral glucose tolerance test (OGTT) (2-hPG), homeostatic model assessment for insulin resistance (HOMA-IR), glycosylated hemoglobin (HbA1c)/total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL-C), low density lipoprotein (LDL-C), body mass index (BMI). After screening, a total of 10 studies (706 participants) remained. Fenugreek significantly reduced FBG, 2-hPG, and HbA1c, but it did not significantly decrease HOMA-IR. Moreover, it significantly improved TC, TG, and HDL-C, while there were no significant differences in LDL-C and BMI. Hepatic or renal toxicity was not observed, and there were no severe adverse events associated with fenugreek despite mild gastrointestinal side effects in some studies. In conclusion, fenugreek improves overall glycemic control parameters and lipid profile safely. Full article
(This article belongs to the Special Issue Food Nutrition and Lipid Metabolism)
Show Figures

Figure 1

Back to TopTop